Type : Bid Notification
****View attachments for full details****
****View attachments for full details****
Please see attachment for solicitation amendment details.
In need of an automated system for molecular testing of solid tumors including colorectal cancer, lung cancer, and melanoma to deliver diagnostic and treatment services to our veterans in a timely manner. To facilitate that objective, a system capable of detecting actionable mutations in genes including BRAF, KRAS, NRAS, and EGFR and Microsatellite Instability (MSI) is required.
The instrument will perform the following testing for patients at University of Illinois Hospital: Microsatellite Instability Testing, Bone Marrow Engraftment analysis, KRAS mutation assay, BRAF V600E mutation, EGFR Mutation, B and T cell clonality, HIV genotyping drug resistance, and others.
, Leukemic Blood 88237; 88264 26 c-KIT Mutation, Liquid Tumor 81272 6 Colorectal Cancer 7 88342; 88341 x3 17 Consult EGL Slides 88323 2 EGFR FISH 88271 (x2) 88274 2 EGFR Mutation Analysis, NSCLC 81235 6 EGFR Mutations 81235;88381 30 Factor II, DNA Analysis #N/A 1 Factor V Leiden Mutation #N/A 1 FISH analyze 100-300 cells additonal probes 88275 347 FISH analyze 100-300 cells 1 88275 21 FISH DNA Probe additional probe 88271 116 Flow Comprehensive Screening
Testing methodology Ability to detect cancer relevant biomarkers across tumor types. This includes gene alterations, tumor mutation burden, microsatellite instability, loss of heterozygosity (LOH), homologous recombination deficiency (HRD).
26 c-KIT Mutation, Liquid Tumor 81272 6 Colorectal Cancer 7 88342; 88341 x3 17 Consult EGL Slides 88323 2 EGFR FISH 88271 (x2) 88274 2 EGFR Mutation Analysis, NSCLC 81235 6 EGFR Mutations 81235;88381 30 Factor II, DNA Analysis #N/A 1 Factor V Leiden Mutation #N/A 1 FISH analyze 100-300 cells additional probes 88275 347 FISH analyze 100-300 cells 1 88275 21 FISH DNA Probe additional probe 88271 116 Flow Comprehensive Screening 88184; 88185x23; 88189